Literature DB >> 21084458

Multilaboratory comparison of Streptococcus pneumoniae opsonophagocytic killing assays and their level of agreement for the determination of functional antibody activity in human reference sera.

Charles E Rose1, Sandra Romero-Steiner, Robert L Burton, George M Carlone, David Goldblatt, Moon H Nahm, Lindsey Ashton, Mitch Haston, Nina Ekström, Raili Haikala, Helena Käyhty, Isabelle Henckaerts, Nathalie Durant, Jan T Poolman, Phil Fernsten, Xinhong Yu, Branda T Hu, Kathrin U Jansen, Milan Blake, Elles R Simonetti, Peter W M Hermans, Brian D Plikaytis.   

Abstract

Antibody-mediated killing of Streptococcus pneumoniae (pneumococcus) by phagocytes is an important mechanism of protection of the human host against pneumococcal infections. Measurement of opsonophagocytic antibodies by use of a standardized opsonophagocytic assay (OPA) is important for the evaluation of candidate vaccines and required for the licensure of new pneumococcal conjugate vaccine formulations. We assessed agreement among six laboratories that used their own optimized OPAs on a panel of 16 human reference sera for 13 pneumococcal serotypes. Consensus titers, estimated using an analysis-of-variance (ANOVA) mixed-effects model, provided a common reference for assessing agreement among these laboratories. Agreement was evaluated in terms of assay accuracy, reproducibility, repeatability, precision, and bias. We also reviewed four acceptance criterion intervals for assessing the comparability of protocols when assaying the same reference sera. The precision, accuracy, and concordance results among laboratories and the consensus titers revealed acceptable agreement. The results of this study indicate that the bioassays evaluated in this study are robust, and the resultant OPA values are reproducible for the determination of functional antibody titers specific to 13 pneumococcal serotypes when performed by laboratories using highly standardized but not identical assays. The statistical methodologies employed in this study may serve as a template for evaluating future multilaboratory studies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21084458      PMCID: PMC3019776          DOI: 10.1128/CVI.00370-10

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  23 in total

1.  Development of a multi-specificity opsonophagocytic killing assay.

Authors:  M H Nahm; D E Briles; X Yu
Journal:  Vaccine       Date:  2000-06-01       Impact factor: 3.641

2.  Standardization of an opsonophagocytic assay for the measurement of functional antibody activity against Streptococcus pneumoniae using differentiated HL-60 cells.

Authors:  S Romero-Steiner; D Libutti; L B Pais; J Dykes; P Anderson; J C Whitin; H L Keyserling; G M Carlone
Journal:  Clin Diagn Lab Immunol       Date:  1997-07

3.  Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors: 
Journal:  MMWR Recomm Rep       Date:  1997-04-04

Review 4.  Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants.

Authors:  Luis Jódar; Jay Butler; George Carlone; Ron Dagan; David Goldblatt; Helena Käyhty; Keith Klugman; Brian Plikaytis; George Siber; Robert Kohberger; Ih Chang; Thomas Cherian
Journal:  Vaccine       Date:  2003-07-04       Impact factor: 3.641

5.  A concordance correlation coefficient to evaluate reproducibility.

Authors:  L I Lin
Journal:  Biometrics       Date:  1989-03       Impact factor: 2.571

6.  Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors: 
Journal:  MMWR Recomm Rep       Date:  2000-10-06

7.  Licensure of a 13-valent pneumococcal conjugate vaccine (PCV13) and recommendations for use among children - Advisory Committee on Immunization Practices (ACIP), 2010.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2010-03-12       Impact factor: 17.586

8.  Multilaboratory evaluation of a viability assay for measurement of opsonophagocytic antibodies specific to the capsular polysaccharides of Streptococcus pneumoniae.

Authors:  Sandra Romero-Steiner; Carl Frasch; Nelydia Concepcion; David Goldblatt; Helena Käyhty; Merja Väkeväinen; Craig Laferriere; Dominique Wauters; Moon H Nahm; Mark F Schinsky; Brian D Plikaytis; George M Carlone
Journal:  Clin Diagn Lab Immunol       Date:  2003-11

9.  Multiplex opsonophagocytosis assay (MOPA): a useful tool for the monitoring of the 7-valent pneumococcal conjugate vaccine.

Authors:  D Bogaert; M Sluijter; R De Groot; P W M Hermans
Journal:  Vaccine       Date:  2004-09-28       Impact factor: 3.641

Review 10.  The role of complement in the host's defense against Streptococcus pneumoniae.

Authors:  J A Winkelstein
Journal:  Rev Infect Dis       Date:  1981 Mar-Apr
View more
  20 in total

1.  Poor Correlation between Pneumococcal IgG and IgM Titers and Opsonophagocytic Activity in Vaccinated Patients with Multiple Myeloma and Waldenstrom's Macroglobulinemia.

Authors:  Johanna Karlsson; Lucy Roalfe; Harriet Hogevik; Marta Zancolli; Björn Andréasson; David Goldblatt; Christine Wennerås
Journal:  Clin Vaccine Immunol       Date:  2016-04-04

2.  Improving vaccines against Streptococcus pneumoniae using synthetic glycans.

Authors:  Paulina Kaplonek; Naeem Khan; Katrin Reppe; Benjamin Schumann; Madhu Emmadi; Marilda P Lisboa; Fei-Fei Xu; Adam D J Calow; Sharavathi G Parameswarappa; Martin Witzenrath; Claney L Pereira; Peter H Seeberger
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-07       Impact factor: 11.205

3.  Interlaboratory standardization of the sandwich enzyme-linked immunosorbent assay designed for MATS, a rapid, reproducible method for estimating the strain coverage of investigational vaccines.

Authors:  Brian D Plikaytis; Maria Stella; Giuseppe Boccadifuoco; Lisa M DeTora; Mauro Agnusdei; Laura Santini; Brunella Brunelli; Luca Orlandi; Isabella Simmini; Marzia Giuliani; Morgan Ledroit; Eva Hong; Muhamed-Kheir Taha; Kim Ellie; Gowrisankar Rajam; George M Carlone; Heike Claus; Ulrich Vogel; Ray Borrow; Jamie Findlow; Stefanie Gilchrist; Paola Stefanelli; Cecilia Fazio; Anna Carannante; Jan Oksnes; Elisabeth Fritzsønn; Anne-Marie Klem; Dominique A Caugant; Raquel Abad; Julio A Vázquez; Rino Rappuoli; Mariagrazia Pizza; John J Donnelly; Duccio Medini
Journal:  Clin Vaccine Immunol       Date:  2012-08-08

4.  Assignment of Opsonic Values to Pneumococcal Reference Serum 007sp for Use in Opsonophagocytic Assays for 13 Serotypes.

Authors:  R L Burton; J Antonello; D Cooper; D Goldblatt; K H Kim; B D Plikaytis; L Roalfe; D Wauters; F Williams; G L Xie; M H Nahm; M Akkoyunlu
Journal:  Clin Vaccine Immunol       Date:  2017-02-06

5.  RrgB321, a fusion protein of the three variants of the pneumococcal pilus backbone RrgB, is protective in vivo and elicits opsonic antibodies.

Authors:  Carole Harfouche; Sara Filippini; Claudia Gianfaldoni; Paolo Ruggiero; Monica Moschioni; Silvia Maccari; Laura Pancotto; Letizia Arcidiacono; Bruno Galletti; Stefano Censini; Elena Mori; Marzia Giuliani; Claudia Facciotti; Elena Cartocci; Silvana Savino; Francesco Doro; Michele Pallaoro; Salvatore Nocadello; Giuseppe Mancuso; Mitch Haston; David Goldblatt; Michèle A Barocchi; Mariagrazia Pizza; Rino Rappuoli; Vega Masignani
Journal:  Infect Immun       Date:  2011-11-14       Impact factor: 3.441

6.  Prediction of pneumococcal conjugate vaccine effectiveness against invasive pneumococcal disease using opsonophagocytic activity and antibody concentrations determined by enzyme-linked immunosorbent assay with 22F adsorption.

Authors:  L Schuerman; J Wysocki; J C Tejedor; M Knuf; K-H Kim; J Poolman
Journal:  Clin Vaccine Immunol       Date:  2011-10-12

7.  Antibodies to the HMW1/HMW2 and Hia adhesins of nontypeable haemophilus influenzae mediate broad-based opsonophagocytic killing of homologous and heterologous strains.

Authors:  Linda E Winter; Stephen J Barenkamp
Journal:  Clin Vaccine Immunol       Date:  2014-02-26

Review 8.  Serotype-independent pneumococcal vaccines.

Authors:  Eliane Namie Miyaji; Maria Leonor Sarno Oliveira; Eneas Carvalho; Paulo Lee Ho
Journal:  Cell Mol Life Sci       Date:  2012-12-27       Impact factor: 9.261

9.  Development and Qualification of an Opsonophagocytic Killing Assay To Assess Immunogenicity of a Bioconjugated Escherichia coli Vaccine.

Authors:  Darren Abbanat; Todd A Davies; Karen Amsler; Wenping He; Kellen Fae; Sarah Janssen; Jan T Poolman; Germie P J M van den Dobbelsteen
Journal:  Clin Vaccine Immunol       Date:  2017-12-05

10.  Pediatric invasive pneumococcal disease caused by vaccine serotypes following the introduction of conjugate vaccination in Denmark.

Authors:  Zitta B Harboe; Palle Valentiner-Branth; Helene Ingels; Jeppe N Rasmussen; Peter H S Andersen; Catherine C Bjerre; David Goldblatt; Lindsey Ashton; Mitch Haston; Helle B Konradsen; Lotte Lambertsen
Journal:  PLoS One       Date:  2013-01-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.